Foresight Group has invested £5.75 million in Functional Gut Group to support its expansion and innovation in digestive health diagnostics.

Target Company Overview

Functional Gut Group (FGG), founded in 2014 by Dr. Anthony Hobson, is dedicated to providing high-quality diagnostic testing services for patients with various digestive health issues, including conditions like Irritable Bowel Syndrome (IBS), which affects approximately one in five individuals in the UK. With three established clinics located in Manchester, Cambridge, and London, as well as several collaborative clinics throughout the UK and Ireland, FGG employs a team of 35 skilled professionals.

In the past year, FGG successfully provided diagnostic testing for over 12,000 patients, serving both the private sector and the National Health Service (NHS). As the only independent gastrointestinal physiology service in the UK recognized with the Improving Quality in Physiological Services accreditation, FGG's clinics are corroborated by inspections from the Care Quality Commission. Additionally, the company offers an accessible online preventive health platform, Tummy MOT®, providing customers with evidence-based education and product assessments related to gut health while also conducting clinical trials for leading global clients.

Industry Overview in the UK

The healthcare sector in the UK has been experiencing significant growth, particularly in the domain of diagnostic services, driven by an increasing demand for specialized medical care and early detection of